List of works - Lisa M DeAngelis

Glioblastoma and other malignant gliomas: a clinical review.

scientific article

Brain tumors

scientific article published on 01 January 2001

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

scientific article

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

scientific article

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

scientific article published on 04 March 2008

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

scientific article published in August 2006

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

scientific article published in August 2005

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

scientific article

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

scientific article

Long-term survival in primary CNS lymphoma

scientific article published on 01 March 1998

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

scientific article

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors

scientific article

An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway

scientific article published on 15 September 2011

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy

scientific article

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

scientific article

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study

scientific article

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

scientific article published in November 2003

Leptomeningeal metastases in the MRI era.

scientific article

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

scientific article

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas

scientific article published in October 2006

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

scientific article

Brain metastases

scientific article published on 01 February 2003

Low-grade oligodendroglioma responds to chemotherapy

scientific article published in January 1996

Treatment of Brain Metastases.

scientific article

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

scientific article

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

scientific article published on 09 May 2016

Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy

scientific article published on February 2012

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

scientific article published on October 1, 1997

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

scientific article published on October 19, 2011

Current diagnosis and treatment of leptomeningeal metastasis

scientific article published on 01 June 1998

Emerging therapies for glioblastoma

scientific article

An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions

scientific article published on 01 September 2000

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

scientific article published on 28 June 2009

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

scientific article

Survey of treatment recommendations for anaplastic oligodendroglioma

scientific article

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

scientific article published on July 8, 2011

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

scientific article

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

scientific article

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

scientific article published on 01 February 1996

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

scientific article published on 01 September 2007

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

scientific article

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

scientific article published in August 2006

Therapy of chemotherapy-induced peripheral neuropathy.

scientific article published on 16 January 2009

Risk of Arterial Thromboembolism in Patients With Cancer.

scientific article

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

scientific article published on 01 June 2002

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

scientific article published on 05 August 2011

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

scientific article

Steroid myopathy in cancer patients.

scientific article published on May 1997

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

scientific article published on 17 September 2008

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

scientific article

List of works by Lisa M DeAngelis

Glioblastoma and other malignant gliomas: a clinical review.

Brain tumors

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas

Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme.

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

Long-term survival in primary CNS lymphoma

Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors

An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway

EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy

Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome

Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

Leptomeningeal metastases in the MRI era.

Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02).

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas

Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

Brain metastases

Low-grade oligodendroglioma responds to chemotherapy

Treatment of Brain Metastases.

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid

Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

Cognitive functions in primary CNS lymphoma after single or combined modality regimens

Current diagnosis and treatment of leptomeningeal metastasis

Emerging therapies for glioblastoma

An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functions

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Survey of treatment recommendations for anaplastic oligodendroglioma

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery

Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients

Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study.

Therapy of chemotherapy-induced peripheral neuropathy.

Risk of Arterial Thromboembolism in Patients With Cancer.

Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02.

Steroid myopathy in cancer patients.

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?